The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 231-240

  Lamb, David J ^a   Ferns, Gordon A A ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; BCG; Cholesterol fed rabbit; Heat shock protein

Indexed keywords

BCG VACCINE; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G; MYCOBACTERIUM ANTIGEN; SODIUM CHLORIDE; BACTERIAL PROTEIN; CHAPERONIN; HEAT SHOCK PROTEIN 65, MYCOBACTERIUM; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BCG VACCINATION; CHOLESTEROL DIET; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTIBODY PRODUCTION; ARTERIOSCLEROSIS; ATHEROGENIC DIET; BLOOD; CHOLESTEROL INTAKE; CORONARY ARTERY DISEASE; DISEASE MODEL; IMMUNIZATION; IMMUNOLOGY; PATHOLOGY; RABBIT; THORACIC AORTA;

ANIMALS; ANTIBODY FORMATION; AORTA, THORACIC; ARTERIOSCLEROSIS; BACTERIAL PROTEINS; BCG VACCINE; CHAPERONINS; CHOLESTEROL, DIETARY; CORONARY DISEASE; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; IMMUNIZATION; RABBITS;

EID: 0036889655     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00244-7     Document Type: Article

References (39)

1. Danesh J., Collins R., Peto R. Chronic infection and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
2. Epstein S.E., Zhu J., Burnett M.S., Zhou Y.F., Vercellotti G., Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler. Thromb. Vasc. Biol. 20:2000;1417-1420.
3. Birnie D.H., Holme E.R., McKay I.C., Hood S., McColl K.E., Hillis W.S. Association between antibodies to heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur. Heart J. 19:1998;387-394.
4. Xu Q., Willeit J., Marosi M., et al. Association of serum antibodies to heat shock-protein 65 with carotid atherosclerosis. Lancet. 341:1993;256-259.
5. Gruber R., Lederer S., Bechtel U., Lob S., Riethmüller G., Feucht H.E. Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis. Int. Arch. Allergy Immunol. 110:1996;95-98.
6. Hoppichler F., Lechleitner M., Tragweger C., Schett G., Dzien A., Sturm W., Xu Q. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis. 126:1996;333-338.
7. Mukherjee M., De Benedictis C., Jewitt D., Kakkar V.V. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis. Thromb. Haemost. 75:1996;258-260.
8. Xu Q., Kiechl S., Mayr M., et al. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis:clinical significance determined in a follow-up study. Circulation. 100:1999;1169-1174.
9. Schett G., Xu Q., Amberger A., van der Zee R., Recheis H., Willeit J., Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 96:1995;2569-2577.
10. Metzler B., Schett G., Kleindienst R., et al. Epitope specificity of anti-heat shock protein 60/65 serum antibodies in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;536-541.
11. Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q., Wick G. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 99:1999;1560-1566.
12. Schett G., Metzler B., Mayr B., et al. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis. 128:1997;27-38.
13. Xu Q., Leuf G., Weimann S., Gupta R.S., Wolf H., Wick G. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler. Thromb. 13:1993;1763-1769.
14. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q. Infections, immunity and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori and Cytomegalovirus with immune reactions to heat shock protein 60 and carotid or femoral atherosclerosis. Circulation. 102:2000;833-839.
15. Xu Q., Schett G., Perschinka H., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 102:2000;14-20.
16. Lamb D.J., Eales L.-J., Ferns G.A.A. Immunisation with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis. 143:1999;105-113.
17. Rutherford C., Martin W., Carrier M., Anggard E.E., Ferns G.A.A. Endogenously elicited antibodies to platelet derived growth factor-BB and platelet cytosolic protein inhibit aortic lesion development in the cholesterol-fed rabbit. Int. J. Exp. Pathol. 78:1997;21-32.
18. Edgell C.J.S., McDonald C.C., Graham J.B. Permanent cell line expressing factor VIII related antigen established by hybridization. Proc. Natl. Acad. Sci. USA. 80:1983;3734-3737.
19. Rieber A.J., Marr H.S., Comer M.B., Edgell C.J.S. Extent of differentiated gene expression in human endothelium-derived EA.hy926. Thromb. Haemost. 69:1993;476-480.
20. Sander B., Skansen-Saphir U., Damm O., Hakansson L., Andersson U. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette Guerin. Immunology. 86:1995;512-518.
21. Mustafa A.S., Lundin K.E., Oftung F. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae. Infect. Immun. 61:1993;5294-5301.
22. Andersen P., Askgaard D., Ljungqvist L., Bentzon M.W., Heron L. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 59:1991;1558-1563.
23. Ladel C.H., Hess J., Daugelat S., Mombaerts P., Toneegawa S., Kaufmann S.H.E. Contribution of α/β and γ/δ T-lymphocytes to immunity against Mycobacterium bovis Bacillus Calmette-Guerin: studies with T-cell receptor-deficient mice. Eur. J. Immunol. 25:1995;838-846.
24. Jackson A.M., Lien E., Alexandroff A.B., et al. Soluble urinary CD14 after intravesical bacille Calmette-Guerin immunotherapy for carcinoma in situ. Br. J. Urol. 80:1997;766-771.
25. Hanano R., Kaufmann S.H. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation. Immunol. Lett. 45:1995;23-27.
26. Tokunaga T., Yano O., Kuramoto E., Kimura Y., Yamamoto T., Kataoka T., Yamamoto S. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 36:1992;55-66.
27. Banerjee D.K., Sharp A.K., Lowrie D.B. The effect of gamma-interferon during Mycobacterium bovis (BCG) infection in athymic and euthymic mice. Microb. Pathog. 1:1986;221-224.
28. Conti P., Reale M., Nicolai M., Barbacane R.C., Placido F.C., Iantorno R., Tenaglia R. Bacillus Calmettte-Guerin potentiates monocyte responses to lipopolysaccharide-induced tumour necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patients. Cancer Immunol. Immunother. 38:1994;365-371.
29. Xu Q., Dietrich H., Steiner H.J., et al. Induction of atherosclerosis in normocholesterolaemic rabbits by immunisation with heat shock protein 65. Arterioscler. Thromb. 12:1992;789-799.
30. Xu Q., Kleindienst R., Waitz W., Diertrich H., Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91:1993;2693-2702.
31. Metzler B., Mayr M., Dietrich H., Singh M., Wiebe E., Xu Q., Wick G. Inhibition of arteriosclerosis by T-cell depletion in normocholesterolaemic rabbits immunised with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 19:1999;1905-1911.
32. Xu Q., Kleindienst R., Schett G., et al. Regression of arteriosclerotic lesions induced by immunisation with heat shock protein 65-containing material in normocholesterolaemic, but not hypercholesterolaemic rabbits. Atherosclerosis. 123:1996;145-155.
33. George J., Shoenfeld Y., Afek A., et al. Enhanced fatty strek formation in C57BL/6J mice by immunisation with heat shock protein-65. Arterioscler. Thromb. Vasc. Biol. 19:1999;505-510.
34. Blann A.D., McCollum C.N. Von Willebrand factor, endothelial damage and atherosclerosis. Eur. J. Vasc. Surg. 8:1994;10-15.
35. Khan I.U., Wallin R., Gupta R.S., Kammer G.M. Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane. Proc. Natl. Acad. Sci. USA. 95:1998;10 425-10 430.
36. Kol A., Bourcier T., Lichtman A.H., Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103:1999;571-577.
37. Schett G., Metzler B., Kleindienst R., Amberger A., Recheis H., Xu Q., Wick G. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc. Res. 42:1999;685-695.
38. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick G. Immunology of atherosclerosis: demonstration of heat shock protein-60 expression and T lymphocytes bearing α/β or γ/δ receptor in human atherosclerotic lesions. Am. J. Pathol. 142:1993;1927-1937.
39. Xu Q., Leuf G., Weimann S., Gupta R.S., Wolf H., Wick G. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler. Thromb. 13:1993;1763-1769.